What Causes a Swollen Retina? Symptoms and Treatment

A swollen retina, known medically as macular edema, happens when fluid leaks into the central part of the retina and gets trapped there. The retina has a protective lining called the blood-retinal barrier that normally keeps fluid, proteins, and other blood components from seeping into the tissue. When disease, injury, or medication damages that barrier, proteins escape into the retinal tissue and draw water in after them through osmosis. The macula, the small central zone responsible for sharp, detailed vision, is especially prone to this buildup because of its high metabolic activity and limited ability to drain excess fluid.

Normal retinal thickness at the center measures roughly 200 to 250 microns. When swelling pushes that number higher, vision starts to blur, straight lines may appear wavy, and colors can look washed out. Several conditions can trigger this process, and most of them share the same final step: a broken barrier and fluid where it doesn’t belong.

Diabetes Is the Most Common Cause

Persistently high blood sugar damages the tiny blood vessels in the retina over time. The vessel walls weaken, and cells that normally form the barrier between blood and retinal tissue begin to die off. As oxygen delivery falters, retinal cells respond by producing a signaling protein called vascular endothelial growth factor, or VEGF. In small amounts VEGF helps maintain healthy blood vessels, but in excess it makes capillary walls far more permeable. Fluid, proteins, and lipids leak through into the surrounding retinal layers.

VEGF also stimulates the growth of new, fragile blood vessels that are even leakier than the damaged originals. These new vessels can bleed into the retina and trigger inflammation, which produces still more VEGF, creating a cycle that progressively worsens the swelling. This is why diabetic macular edema can develop gradually over years yet accelerate once it reaches a tipping point. Keeping blood sugar, blood pressure, and cholesterol well controlled slows the damage to those tiny vessels and reduces the risk of barrier breakdown.

Age-Related Macular Degeneration

About 10% of people with age-related macular degeneration (AMD) develop the “wet” form, in which abnormal blood vessels grow upward from beneath the retina, pushing through a thin membrane that normally separates the blood supply from the retinal layers. These new vessels are structurally weak. They leak fluid, blood, and fatty deposits into and under the retina, causing rapid swelling and distortion of central vision. Left untreated, the leaking vessels eventually form scar tissue that permanently destroys the overlying photoreceptors.

VEGF plays a central role here too. It accumulates in areas of the retina that aren’t getting enough oxygen and drives the new vessel growth. The process can be quite sudden compared to diabetic swelling. People with wet AMD often notice that straight lines look bent or that a dark spot appears in the center of their vision over the course of days or weeks rather than months.

Retinal Vein Blockages

A blood clot or narrowing in one of the veins that drains blood from the retina raises pressure inside the smaller vessels upstream. That increased pressure forces fluid and blood components through the vessel walls and into the retinal tissue. The resulting swelling can be dramatic, causing a sudden drop in vision. The blocked vein also creates areas of oxygen deprivation, which triggers the same VEGF-driven leakage cycle seen in diabetes and wet AMD.

Inflammation Inside the Eye

Uveitis, inflammation of the inner eye structures, is another significant cause. The inflammation can stem from autoimmune conditions like sarcoidosis, Behçet disease, or Vogt-Koyanagi-Harada disease, as well as infections including toxoplasmosis, tuberculosis, and certain herpes viruses. In some cases no underlying cause is ever identified.

When inflammation flares, immune cells release a cocktail of signaling molecules, including VEGF, tumor necrosis factor, histamine, and several interleukins. These collectively loosen the blood-retinal barrier and cause the specialized support cells in the retina (Müller cells) to swell. Fluid then collects in cyst-like pockets, primarily in the outer layers of the macula. This type of swelling can recur with each inflammatory episode, so controlling the underlying inflammation is critical to preventing repeated damage.

Post-Surgical Swelling

Cataract surgery is one of the most common operations worldwide, and roughly 0.8% of eyes develop retinal swelling afterward, a condition sometimes called Irvine-Gass syndrome. The average onset is about six weeks after the procedure. Surgical manipulation releases inflammatory mediators inside the eye, which travel to the macula and disrupt the barrier. In most cases the swelling resolves with anti-inflammatory eye drops, but a small number of patients need additional treatment.

Medications That Can Trigger Swelling

Certain prescription drugs are known to cause macular edema as a side effect. Thiazolidinediones, a class of diabetes medications, have been implicated, which creates an ironic situation for patients already at risk from the diabetes itself. Fingolimod, used for relapsing multiple sclerosis, carries a well-documented risk. The cancer drugs tamoxifen and taxanes, along with niacin (high-dose vitamin B3) and interferons, have also been linked to retinal swelling.

Even some eye drops can be responsible. Prostaglandin analogs prescribed for glaucoma, certain formulations of epinephrine, and preservatives used in ophthalmic solutions have all been reported to cause fluid buildup in the macula. The swelling typically improves once the medication is stopped or switched, though recovery can take weeks.

What Retinal Swelling Feels Like

The hallmark symptom is blurred central vision that doesn’t improve with glasses. Many people describe it as looking through water or a smudged lens. Straight lines, like door frames or text on a screen, may appear wavy or bent. Colors can seem faded, and some people notice a dim or dark patch near the center of their visual field. Peripheral vision usually remains intact, which is why the condition can sneak up on you: you can still see around the room, but reading, recognizing faces, and driving become increasingly difficult.

Symptoms can develop gradually over weeks in conditions like diabetes or appear within days in wet AMD or a vein blockage. Any sudden change in central vision warrants prompt evaluation.

How It’s Detected and Measured

Optical coherence tomography (OCT) is the standard tool for diagnosing and monitoring retinal swelling. It produces a cross-sectional image of the retina in seconds, showing exactly where fluid has collected and how thick the retina has become. A normal central thickness of 200 to 250 microns serves as the baseline; readings above that range, especially with visible cystic spaces or subretinal fluid pockets, confirm edema. Doctors use repeated OCT scans to track whether treatment is working and to decide when additional intervention is needed.

How Retinal Swelling Is Treated

The first-line treatment for most forms of macular edema is anti-VEGF therapy: injections delivered directly into the eye to block the protein driving the leakage. The procedure sounds alarming, but the needle is extremely fine, numbing drops are applied beforehand, and the injection itself takes only seconds. Studies show meaningful visual improvement, with patients gaining measurable sharpness, often within weeks of the first injection. One recent analysis found median vision improved from roughly 20/50 to 20/44 after a course of treatment, and individual results can be substantially better when treatment starts early.

For cases driven primarily by inflammation, corticosteroid injections or implants placed inside the eye can reduce swelling effectively. These are often used for uveitic macular edema or as a second option when anti-VEGF alone isn’t enough. Laser treatment, once the standard approach, now plays a supporting role. It can seal leaking vessels and reduce fluid production, but it doesn’t restore lost vision the way anti-VEGF therapy can.

In every case the underlying cause matters as much as the swelling itself. Controlling blood sugar in diabetes, suppressing inflammation in uveitis, or discontinuing a problem medication addresses the root of the leakage rather than just mopping up fluid. Treatment plans almost always combine barrier repair (injections, laser) with management of whatever broke the barrier in the first place.